Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0360674466
Tue, 10.03.2026
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica increases sales in 2025 by 5.5% to CHF 4,135.6 million – all business areas contribute to growth.
Adjusted1 EBIT increases by 11.3% to CHF 234.8 million.
Pharmacies strengthen basic care through consultation services.
In Wholesale, modern systems are driving greater efficiency.
T [ … ]
Tue, 24.02.2026
Galenica AG
Bichsel intends to discontinue pharmaceutical production by the end of 2026 at the latest for economic reasons.
This affects up to 170 jobs. The consultation process has been initiated.
In future, Bichsel will focus on its successful home care services.
“Grosse Apotheke Dr. G. Bichsel” will continue to operate as “Amavita Apotheke Bichsel Inte [ … ]
Thu, 22.01.2026
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Sales up by 5.5% to CHF 4,135.6 million
Broad-based growth – with all business areas contributing
Strong pharmacy business driven by prescription medicines and dietary supplements
Continuous growth in wholesale
New “Diagnostics” area contributes 1% to sales growth
EBIT1 guidance with 10- [ … ]
